Conflict Of Interest Protection Of Public Ownership In Drug Development Deals Between Tax Exempt Federally Supported Labs And The Pharmaceutical Industry

Author : United States; Congress; Hou Regulation
Publisher :
ISBN 13 : 9781332256341
Total Pages : 264 pages
Book Rating : 4.2/5 (563 download)

DOWNLOAD NOW!

Download or read book Conflict of Interest, Protection of Public Ownership, in Drug Development Deals Between Tax-Exempt, Federally Supported Labs and the Pharmaceutical Industry written by United States; Congress; Hou Regulation and published by . This book was released on 2015-08-05 with total page 264 pages. Available in PDF, EPUB and Kindle. Book excerpt: Excerpt from Conflict of Interest, Protection of Public Ownership, in Drug Development Deals Between Tax-Exempt, Federally Supported Labs and the Pharmaceutical Industry: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business House Representatives One Hundred Third Congress, First Session, Washington, DC, March 11, 1993 The subcommittee met, pursuant to notice, at 9:38 a.m., in room 2359-A, Rayburn House Office Building, Hon. Ron Wyden, (chairman of the subcommittee) presiding. Chairman Wyden. The subcommittee will come to order. Today, the Subcommittee on Regulation, Business Opportunities, and Technology continues its 2-year-long inquiry into the pricing of drugs and medical devices which is the result of cooperation between taxpayer-supported, nonprofit, research laboratories and the pharmaceutical industry. The potential importance to the Nation's public health of this medical research collaboration is not in dispute. From these projects flow life-enhancing treatments for cancer, medications for cardiovascular disease, and cures for diseases and conditions that formerly meant death or a lifetime of disability for many of our fellow citizens. But this collaboration over time also has cemented the economic foundation of a very large, very profitable industry. On a continuing and increasing basis, the pharmaceutical industry mines a mother lode of valuable medical discoveries from a laboratory system that Federal taxpayers support with almost $10 billion per year. Of this $10 billion, $3 dollars of every $4 go to a university or independent lab. The Federal administrators who supervise this system appear to have little control over the prices charged by private drug manufacturers, who are their partners in either project-specific or broad-based research ventures. This system results in the commercialization of drugs discovered and developed in Federal laboratories, then priced out of sight by the pharmaceutical industry. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.